Earlier this month, the United States government stated that they aim to save taxpayers around $6 billion on the prices for 10 widely used prescription drugs under its new authority to leverage Medicare’s market power as well as reduce the cost of brand-name medicines. The prices, which are associated with two popular blood thinners, several…